202 related articles for article (PubMed ID: 10341706)
1. Insights into cancer from transgenic mouse models.
Macleod KF; Jacks T
J Pathol; 1999 Jan; 187(1):43-60. PubMed ID: 10341706
[TBL] [Abstract][Full Text] [Related]
2. New approaches for modelling cancer mechanisms in the mouse.
Maddison K; Clarke AR
J Pathol; 2005 Jan; 205(2):181-93. PubMed ID: 15641017
[TBL] [Abstract][Full Text] [Related]
3. Probing p53 biological functions through the use of genetically engineered mouse models.
Attardi LD; Donehower LA
Mutat Res; 2005 Aug; 576(1-2):4-21. PubMed ID: 16038709
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mouse models of human breast cancer.
Hutchinson JN; Muller WJ
Oncogene; 2000 Dec; 19(53):6130-7. PubMed ID: 11156526
[TBL] [Abstract][Full Text] [Related]
5. [Spatio-temporal control of oncogenesis].
Giovannini M
Pathol Biol (Paris); 1998 Feb; 46(2):120-1. PubMed ID: 9769926
[TBL] [Abstract][Full Text] [Related]
6. Mammary gland neoplasia: insights from transgenic mouse models.
Siegel PM; Hardy WR; Muller WJ
Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
[TBL] [Abstract][Full Text] [Related]
9. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in research on multistage tumorigenesis.
Compagni A; Christofori G
Br J Cancer; 2000 Jul; 83(1):1-5. PubMed ID: 10883659
[TBL] [Abstract][Full Text] [Related]
11. Conditional mouse models of sporadic cancer.
Jonkers J; Berns A
Nat Rev Cancer; 2002 Apr; 2(4):251-65. PubMed ID: 12001987
[TBL] [Abstract][Full Text] [Related]
12. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
Kasper S
J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
[TBL] [Abstract][Full Text] [Related]
13. Role of transgenic mice in identification and characterization of tumour suppressor genes.
Sharan SK; Bradley A
Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
15. Medicine. Building better mouse models for studying cancer.
Marx J
Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
[No Abstract] [Full Text] [Related]
16. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
17. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of multi-stage tumorigenesis in transgenic mice.
Christofori G; Hanahan D
Semin Cancer Biol; 1994 Feb; 5(1):3-12. PubMed ID: 8186386
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.
Bergers G; Hanahan D; Coussens LM
Int J Dev Biol; 1998; 42(7):995-1002. PubMed ID: 9853830
[TBL] [Abstract][Full Text] [Related]
20. Modeling prostate cancer: a perspective on transgenic mouse models.
Jeet V; Russell PJ; Khatri A
Cancer Metastasis Rev; 2010 Mar; 29(1):123-42. PubMed ID: 20143131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]